Follow
Francesco Forconi
Francesco Forconi
University of Southampton OR University of Siena
Verified email at soton.ac.uk - Homepage
Title
Cited by
Cited by
Year
BRAF mutations in hairy-cell leukemia
E Tiacci, V Trifonov, G Schiavoni, A Holmes, W Kern, MP Martelli, ...
New England Journal of Medicine 364 (24), 2305-2315, 2011
11982011
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ...
Journal of Experimental Medicine 208 (7), 1389-1401, 2011
7812011
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ...
Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013
5962013
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
D Rossi, S Rasi, G Fabbri, V Spina, M Fangazio, F Forconi, R Marasca, ...
Blood, The Journal of the American Society of Hematology 119 (2), 521-529, 2012
5552012
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ...
Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011
4832011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3391-3401, 2011
4142011
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness
D Rossi, M Cerri, C Deambrogi, E Sozzi, S Cresta, S Rasi, L De Paoli, ...
Clinical cancer research 15 (3), 995-1004, 2009
4022009
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012
3892012
Perturbation of the normal immune system in patients with CLL
F Forconi, P Moss
Blood, The Journal of the American Society of Hematology 126 (5), 573-581, 2015
3582015
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre …
M Bocchia, S Gentili, E Abruzzese, A Fanelli, F Iuliano, A Tabilio, ...
The Lancet 365 (9460), 657-662, 2005
3312005
Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
M Else, CE Dearden, E Matutes, J Garcia‐Talavera, AZS Rohatiner, ...
British journal of haematology 145 (6), 733-740, 2009
2982009
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ...
Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013
2772013
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ...
Blood, The Journal of the American Society of Hematology 126 (16), 1921-1924, 2015
2602015
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ...
Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017
2582017
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ...
Clinical Cancer Research 15 (13), 4415-4422, 2009
2502009
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
P Hillmen, AC Rawstron, K Brock, S Muņoz-Vicente, FJ Yates, R Bishop, ...
Journal of clinical oncology 37 (30), 2722, 2019
2412019
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
A Rinaldi, M Mian, E Chigrinova, L Arcaini, G Bhagat, U Novak, ...
Blood, The Journal of the American Society of Hematology 117 (5), 1595-1604, 2011
2052011
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation
E Tiacci, G Schiavoni, F Forconi, A Santi, L Trentin, A Ambrosetti, ...
Blood, The Journal of the American Society of Hematology 119 (1), 192-195, 2012
1982012
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
D Rossi, E Sozzi, A Puma, L De Paoli, S Rasi, V Spina, A Gozzetti, ...
British journal of haematology 146 (1), 64-75, 2009
1872009
High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate
F Lauria, D Raspadori, D Rondelli, MA Ventura, M Fiacchini, G Visani, ...
Leukemia 11 (12), 2075-2078, 1997
1691997
The system can't perform the operation now. Try again later.
Articles 1–20